In patients with type 2 diabetes (T2D), the use of SGLT2 inhibitors significantly increased the risk of falls, and the risk was even higher when combined with GLP-1 receptor agonists. Although GLP-1 RAs alone were not significantly linked to increased falls, combined therapy raised the risk substantially.
Dr. JoAnn Manson, a professor of medicine at Harvard Medical School and Brigham and Women’s Hospital, discussed a recent study presented at the 2025 American Heart Association Epidemiology, Prevention, Lifestyle & Cardiometabolic Health Scientific Sessions in New Orleans. The study, known as the Cocoa Supplement Multivitamins Outcomes Study (COSMOS), explored whether daily multivitamin supplementation could slow biological aging, as measured by DNA methylation in epigenetic clocks.
As we enter 2025, the health technology industry is undergoing a transformation that promises to revolutionize patient care and operational efficiency. Emerging trends in artificial intelligence, remote patient monitoring, and digital therapeutics are reshaping how healthcare is delivered, offering new opportunities to enhance patient outcomes and streamline workflows. Insights from leading organizations such as the American Medical Association, Forbes, and Deloitte highlight the key developments shaping the future of healthcare technology.
New research suggests that clinicians should warn patients about the potential cardiovascular risks of cannabis use, though the extent of the risk depends on the amount used. A 2024 U.S. study of over 430,000 respondents found that daily cannabis users had a 49% increased risk of heart attack and a twofold increased risk of stroke. Even weekly users showed a slight increase in risk. Similar findings were observed in a 2022 Stanford study using UK Biobank data.
Cannabis may contribute to cardiovascular disease through various mechanisms. THC, the psychoactive component, binds to CB1 receptors in the heart and blood vessels, promoting atherosclerosis, inflammation, and oxidative stress. It may also have a prothrombotic effect, increasing the risk of heart attacks and strokes. Studies have linked cannabis use to arrhythmias, particularly atrial fibrillation.
Investing in AI in healthcare requires careful consideration beyond the initial excitement. Many AI projects fail—about 80% compared to 40% for non-AI IT projects—due to high costs, complexity, and scope creep. Experts recommend a methodical approach: think big, start small, and iterate often.